Latest Prescription Drugs news
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
posted March 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
Pelabresib Plus Ruxolitinib Improves Underlying Myelofibrosis
posted March 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Heart Failure Patients With Ejection Fraction Improvement Rarely Withdrawn From Meds
posted March 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Gantenerumab May Slow Decline in Dominantly Inherited Alzheimer Disease
posted March 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors .jpg)
Recommendations Updated for Management of Anemia in CKD 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Voice Disorders Linked to Elevated Risk for Incident Cognitive Decline 
Therapies Compared for Newly Diagnosed Multiple Sclerosis 
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Updated Recommendations Address Medications to Prevent Migraine in Adults Monthly Specialist Briefings
Stay Connected
